Angelo M Taveira-DaSilva
Overview
Explore the profile of Angelo M Taveira-DaSilva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1920
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taveira-DaSilva A, Gopalakrishnan V, Yao J, Chen M, Julien-Williams P, Jones A, et al.
BMC Pulm Med
. 2022 Sep;
22(1):362.
PMID: 36153516
Objectives: Lymphangioleiomyomatosis (LAM) patients with severe lung disease may be considered for lung transplantation. Clinical, physiologic, and quality of life data are usually employed for referral. The aim of this...
2.
Taveira-DaSilva A, Johnson S, Julien-Williams P, Johnson J, Stylianou M, Moss J
Thorax
. 2020 Aug;
75(10):904-907.
PMID: 32788260
Pregnancy in women with lymphangioleiomyomatosis (LAM) has been associated with increased complications and worsening lung function although objective data to advise patients are not available. We assessed lung function and...
3.
Gupta N, Lee H, Young L, Strange C, Moss J, Singer L, et al.
Eur Respir J
. 2019 Mar;
53(4).
PMID: 30846465
Introduction: The Multicenter International Lymphangioleiomyomatosis (LAM) Efficacy of Sirolimus (MILES) trial revealed that sirolimus stabilised lung function in patients with moderately severe LAM. The purpose of this study was to...
4.
Gopalakrishnan V, Yao J, Steagall W, Avila N, Taveira-DaSilva A, Stylianou M, et al.
Chest
. 2019 Jan;
155(5):962-971.
PMID: 30660784
Background: In lymphangioleiomyomatosis (LAM), infiltration of the lungs with smooth muscle-like LAM cells results in cystic destruction and decline in lung function, effects stabilized by sirolimus therapy. LAM lung disease...
5.
Taveira-DaSilva A, Markello T, Kleiner D, Jones A, Groden C, Macnamara E, et al.
J Med Genet
. 2018 Nov;
56(11):778-782.
PMID: 30385646
Background: Copa syndrome is a rare autosomal dominant disorder with abnormal intracellular vesicle trafficking. The objective of this work is to expand the knowledge about this disorder by delineating phenotypic...
6.
Gupta N, Lee H, Ryu J, Taveira-DaSilva A, Beck G, Lee J, et al.
Chest
. 2018 Jun;
155(2):288-296.
PMID: 29940164
Background: The natural history of lymphangioleiomyomatosis (LAM) is mainly derived from retrospective cohort analyses, and it remains incompletely understood. A National Institutes of Health LAM Registry was established to define...
7.
Taveira-DaSilva A, Julien-Williams P, Jones A, Stylianou M, Moss J
Eur Respir J
. 2018 Mar;
51(4).
PMID: 29519926
The value of rates of change in forced expiratory volume in 1 s (FEV) and diffusing capacity of the lung for carbon monoxide () to predict disease progression, and initiation...
8.
Pacheco G, Jones A, Yao J, Kleiner D, Taveira-DaSilva A, Moss J
Chest
. 2018 Feb;
153(2):e19-e23.
PMID: 29406234
We present the case of a man with Mounier-Kuhn syndrome (MKS), or tracheobronchomegaly, who was referred to the National Institutes of Health Clinical Research Center because of a potential diagnosis...
9.
Gupta N, Finlay G, Kotloff R, Strange C, Wilson K, Young L, et al.
Am J Respir Crit Care Med
. 2017 Nov;
196(10):1337-1348.
PMID: 29140122
Background: Recommendations regarding key aspects related to the diagnosis and pharmacological treatment of lymphangioleiomyomatosis (LAM) were recently published. We now provide additional recommendations regarding four specific questions related to the...
10.
Taveira-DaSilva A, Jones A, Julien-Williams P, Stylianou M, Moss J
Chest
. 2017 May;
153(1):124-132.
PMID: 28533049
Background: Sirolimus reduces serum levels of vascular endothelial growth factor D (VEGF-D); the size of chylous effusions, lymphangioleiomyomas, and angiomyolipomas; and stabilizes lung function in patients with lymphangioleiomyomatosis (LAM). Methods:...